Law Firm Probing Potential Conflict with Special Master, Law Firm Staffer Chargd with Inside Trading
Posted on
- “AA staffer at the prestigious white-shoe law firm Cravath, Swaine & Moore was arrested and arraigned Thursday in Brooklyn federal court on charges of insider trading after allegedly using confidential information from clients to inform stock market trades from which he has profited at least $70,000 since April 2025.”
- “Federal prosecutors say processing specialist Chetram Balli, a resident of Hollis, Queens, had worked for Cravath, based in Midtown, since 1989 and allegedly developed a practice of taking advantage of his access to non-public information about roughly half a dozen of the firm’s clients, including financial services company Charles Schwab and media conglomerate Paramount. Cravath represented Paramount in its merger with Warner Bros.”
- “Balli faces up to 20 years in prison if convicted. His attorney, Michael Schneider of Brooklyn Federal Defenders, said his client had no comment on the charges.”
- “A Cravath spokesperson told amNewYork Law that Balli, who was never a member of its legal staff, is no longer employed by the firm. Cravath said it is working in full cooperation with the authorities investigating the matter. The New York-based international firm is not charged with any wrongdoing.”
- “Balli’s work predominantly involved creating and revising complex legal documents that included confidential information about upcoming and unannounced business transactions that impacted stock market shares. He worked in Cravath’s mergers and acquisitions division, which has represented over 800 clients in deals worth over $4 trillion across the past decade, according to the firm.”
- “In one instance, prosecutors allege, Balli purchased shares for marketplace infrastructure company Forge the day before the public learned that Cravath client Charles Schwab would acquire the company for $660 million. That action reaped Balli more than $22,200 in profit.”
- “He allegedly acted similarly regarding stock purchases and sales related to global healthcare company Viatris Inc. and software giant WiseTech. Balli is also accused of using his knowledge of Paramount’s merger with Warner Bros. to obtain over $16,000 in illicit profits via stock trading.”
- “Eastern District of New York prosecutors worked with the Federal Bureau of Investigation (FBI), U.S. Securities and Exchange Commission (SEC) and Financial Industry Regulatory Authority (FINRA) to investigate Balli’s conduct.”
- “‘Balli allegedly turned privileged access into an illegal advantage, repeatedly trading securities ahead of public announcements involving major corporate transactions,’ said FBI Assistant Director in Charge James Barnacle in a statement. ‘By misappropriating confidential information for personal profit, he gained an unfair edge over law-abiding investors and compromised the fairness that our markets depend upon.'”
- “‘May these charges act as a warning to others,’ Barnacle said.”
“Generics MDL Judge Won’t Extend Pause Over Conflict” —
- “A Pennsylvania federal judge refused Friday to extend a pause on the generic-drug price-fixing multidistrict litigation, eyeing setting a new trial date for the first bellwether case initially paused by a conflict with a special master that the drugmakers say now covers ‘the entire MDL.'”
- “In a terse two-page order, U.S. District Judge Cynthia M. Rufe allowed bellwether plaintiff Humana to serve subpoenas on defense counsel with Morgan Lewis & Bockius LLP, Kasowitz LLP and Wilson Sonsini Goodrich Rosati. The goal: to probe when they discovered the potential conflicts with special master, Saxton & Stump LLC shareholder and former U.S. District Judge Lawrence Stengel. Humana says the defendants must have learned of the conflict months or even years before they say they did in August.”
- “Judge Rufe similarly allowed Humana to seek a deposition of Mylan’s new chief legal officer, Matthew Maletta, for the same reason. Just as importantly, the judge appeared to reject the request made Thursday by Mylan, Lannett, Pfizer, Sandoz, Glenmark, Teva and other defendants, who’d wanted the court to extend the initial pause imposed on the Humana bellwether to the rest of the MDL.”
- “The early September order came a day after Mylan said it had only just learned that Judge Stengel served as co-lead counsel with two attorneys representing plaintiffs in a separate case in the MDL with a purportedly similar fact pattern as the upcoming bellwether trial with plaintiff Humana. That case, Mylan said, arose ‘from the same nucleus of facts and claims as those alleged in this MDL, including Humana I.'”
- “Humana has cast doubt on the timing, prompting the early October discovery bid that Judge Rufe addressed Friday. In its motion, Humana sought material on how the defendants’ in-house and outside counsel looked at Judge Stengel as a potential special master. While maintaining that ‘there is no actual conflict; thus, no discovery is necessary,’ Humana said Mylan would have been aware of the potential issues in the spring of 2023, ‘when defendants vetted Judge Stengel for the position of special master.'”
- “‘Mylan forfeited its right to disqualify Judge Stengel, regardless of whether a conflict exists, by failing to object until one week before jury selection in a tactical effort to disrupt the court’s Humana I trial date,’ the insurer said at the time.”
- “In initially seeking a pause in early September, Mylan argued that Judge Stengel worked on a securities case against Endo that was ‘expressly based’ on the claims found in the Humana I complaint. Mylan said Judge Stengel advanced allegations that the generic-drug maker defendants currently involved in Humana I engaged in price-fixing.”
- “Humana countered in its motion a month later, however, that even if Mylan ‘could credibly claim’ ignorance of Judge Stengel’s role in Endo during the 2023 vetting process, it ‘was surely aware no later than February 2026 when former Endo Chief Legal Officer, Mr. Maletta — who in his own words claimed that he supervised that litigation while at Endo — joined Mylan in the same capacity.'”
- “Friday’s order comes a day after the drugmakers said they need a wider pause, and more discovery than Judge Rufe has so far permitted into Judge Stengel’s potential conflict.”








